BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Johnson and Johnson

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,916,893

« Back to Dashboard

Summary for Patent: 5,916,893

Title: Treatment of a latent infection of herpes virus
Abstract:A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.
Inventor(s): Field; Hugh John (Cambridge, GB), Thackray; Alana Maureen (Cambridge, GB), Bacon; Teresa Helen (Epsom, GB), Sutton; David (Phoenixville, PA), Vere Hodge; Richard Anthony (Reigate, GB)
Assignee: SmithKline Beecham p.l.c. (Brentford, GB)
Application Number:08/845,720
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 5,916,893

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9425012Dec 12, 1994
United Kingdom9506663Mar 31, 1995
United Kingdom9517308Aug 24, 1995

International Patent Family for Patent: 5,916,893

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Cyprus2339► Subscribe
Czech Republic9701799► Subscribe
Czech Republic291545► Subscribe
Germany69523776► Subscribe
Denmark0799039► Subscribe
European Patent Office0799039► Subscribe
Hong Kong1003259► Subscribe
Spain2166834► Subscribe
United Kingdom9425012► Subscribe
United Kingdom9506663► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Farmers Insurance
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus